openPR Logo
Press release

GMP Cytokines Market Driven By CellGenix, BIO-TECHNE, Proteintech Group, Sino Biological, REPROCELL

09-08-2021 09:51 AM CET | Health & Medicine

Press release from: The Insight Partners

GMP Cytokines Market

GMP Cytokines Market

According to our new research study on “GMP Cytokines Market Forecast to 2027 – COVID-19 Impact and Analysis – by Type, and Application,” the market is expected to reach US$ 158.13 million in 2027 from US$ 84.72 million in 2019; it is estimated to grow at a CAGR of 8.1% from 2020 to 2027. The report highlights trends prevailing in the global GMP cytokines market and factors governing the market growth.

Miltenyi Biotec; Sino Biological Inc.; ABCAM; PeproTech Inc.; Akron Biotech; CellGenix GmbH; BIO-TECHNE CORPORATION; CREATIVE BIOARRAY; Proteintech Group, Inc.; and REPROCELL Inc. are among the leading companies operating in the GMP cytokines market.

Request for sample PDF copy @ https://www.theinsightpartners.com/sample/TIPRE00008212/?utm_source=OpenPR&utm_medium=10144

Based on type, the growth factors segment held the largest share of the market in 2019; whereas, the TNF segment is expected to grow at the fastest CAGR during the forecast period. TNF-α is cytotoxic to a wide range of tumor cells, and is a vital factor in stimulating immune response against bacterial infections. Increasing prevalence of cancer and infectious diseases is likely to propel the growth of the segment. Additionally, an extensive research study on TNF is likely to favor the growth of the segment during the forecast period. For instance, ‘Nonconventional induction strategies for production of recombinant human tumor necrosis factor-alpha in Escherichia coli’ was published in 2018.

GMP cytokines are used in cell and gene therapy for expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches. Moreover, these are used in various tissue engineered products for clinical applications. Additionally, extensive research is being conducted on cytokines to discover new therapeutic approaches to treat chronic conditions. The growth of the GMP cytokines market is mainly attributed to the factors such as increase in acceptance of cytokines cancer and autoimmune therapies, and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.

Additionally, increasing number of investments and collaborations to develop cytokine therapies over cancer and autoimmune diseases are also expected to accelerate the market growth. For instance, in September 2020, Synthekine Inc. raised US$ 82.0 million through rounds of series funding. The company is engaged in the development of cytokine therapeutics for the treatment of cancer and autoimmune disorders.

GMP Cytokines Market – by Type

TNF
Interleukins
Growth Factors
Others

GMP Cytokines Market – by Application

Cell and Gene Therapy
Tissue Engineered Products

GMP Cytokines Market – by Geography

North America
US
Canada
Mexico
Europe
France
Germany
Italy
UK
Spain
Rest of Europe
Asia Pacific (APAC)
China
India
South Korea
Japan
Australia
Rest of Asia Pacific
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Rest of Middle East and Africa
South and Central America
Brazil
Argentina
Rest of South and Central America

Buy Complete Report Copy @ https://www.theinsightpartners.com/buy/TIPRE00008212/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GMP Cytokines Market Driven By CellGenix, BIO-TECHNE, Proteintech Group, Sino Biological, REPROCELL here

News-ID: 2385450 • Views:

More Releases from The Insight Partners

Denim Fabrics Market by Demand Analysis, Manufacturers Share, Regions, Risk Analysis, Driving Forces and Application, Forecast to 2031
Denim Fabrics Market by Demand Analysis, Manufacturers Share, Regions, Risk Anal …
The Insight Partners adds "Denim Fabrics Market Forecast to 2031 COVID-19 Impact and Global Analysis" to its store providing analysis of the current and future market competition in the market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00018240?utm_source=OpenPR&utm_medium=10881 Key Players Analysis: SANKO Holding Candiani S.p.A. Hyde Park Denim Cone Denim LLC KG DENIM LIMITED Zeva Denim Prosperity Textile T?SA AtlasDenim Arvind Limited The
Split Air Conditioning Market Set for Strong Growth Driven by Energy Efficiency and Smart Home Integration Trends
Split Air Conditioning Market Set for Strong Growth Driven by Energy Efficiency …
New York, US - October 27, 2025 - According to a new report published by The Insight Partners, the Split Air Conditioning Market is projected to witness steady growth from 2025 to 2031, registering a CAGR of XX%. The market size is expected to expand from US$ XX Million in 2024 to US$ XX Million by 2031, fueled by increasing consumer demand for energy-efficient, eco-friendly, and technologically advanced air conditioning
Intelligent Pipeline Pigging Market Projected for 6.3% CAGR Growth During 2025-2031 Forecast Period
Intelligent Pipeline Pigging Market Projected for 6.3% CAGR Growth During 2025-2 …
New York, US - October 27, 2025 - The Intelligent Pipeline Pigging Market is poised for steady expansion, reaching US$ 1,244.2 million by 2031, up from US$ 782.3 million in 2023, registering a CAGR of 6.3% from 2025 to 2031. This strong trajectory highlights the growing importance of advanced pigging solutions that enhance pipeline integrity, operational efficiency, and environmental safety. As global energy and utility networks continue to expand, the demand
Biopharmaceutical Tubing Market to Reach US$ 7.64 Billion by 2031, Growing at 8.3% CAGR
Biopharmaceutical Tubing Market to Reach US$ 7.64 Billion by 2031, Growing at 8. …
The Insight Partners is proud to announce its latest report, "Biopharmaceutical Tubing Market - Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2031." The report provides a comprehensive analysis of the Biopharmaceutical Tubing Market, covering market trends, growth dynamics, technological advancements, and competitive developments shaping the future of bioprocessing and pharmaceutical manufacturing. Check valuable insights in the Biopharmaceutical Tubing Market report. You can easily get a sample PDF of the

All 5 Releases


More Releases for GMP

Creative Peptides Released GMP Synthesis Service
Located in Shirley, New York, the world’s leading peptide supplier Creative Peptides announced the launch of its GMP synthesis (https://www.creative-peptides.com/services/custom-gmp-peptide-synthesis-services.html ) business on August 29, 2018. Now this company is focused on the development and GMP manufacturing of pharmaceutical grade peptides. As the demand of pharmaceutical market continues to grow, more and more pharmas and research institutions choose the CMO and CRO models to expand their businesses, which is more
Diapharm implements European GMP guidelines in China
Münster (DE), London (UK), Ningbo (CN), 20 December 2013 – Pharmaceutical service provider Diapharm (diapharm.com) is increasing its business activities in China: Diapharm has now implemented a “European” quality management system for Neptune Pharma Ltd (www.neptunepharma.com) in their Joint Venture Partner’s factory in Ningbo, Zhejiang Province. And it has done so successfully: The veterinary medicinal product Trident 500mg/g Powder for Suspension for Fish Treatment (www.trident-50.com), is manufactured onsite under EU
ECA Foundation releases free GMP WebApp
The ECA Foundation has been providing advanced training and information services in the pharmaceutical industry and especially with regard to pharmaceutical Quality Assurance and GMP compliance for more than 10 years. Now the organisation took advantage of its extensive experience to develop a further free of charge service – the new GMP WebApp. This new GMP WebApp runs on all smartphones and tablet PCs (Apple and Android platforms) and allows users
GMP Friction Products Awarded ISO 9001:2008
Internationally Recognized Certification Measures Consistency in Process, Procedure and Quality Performance in Manufacture of Friction Materials AKRON, OH (March 23, 2011) -- GMP Friction Products, a world leader manufacturing powdered metal friction products for clutch plates and brake pads, recently received certification for ISO 9001:2008. “ISO 9001:2008 signifies we have taken the extra measure of documenting the policies and standards to ensure consistent compliance with our manufacturing processes,” said Jerry Lynch,
GMP MANUAL Volume 2 - Validation Procedures by Maas & Peither AG – GMP Publish …
GMP Publishing is launching its new GMP MANUAL Volume 2 – Validation Procedures. The compendium on validation procedures was written by Dr. Doris Borchert, Dr. Peter Bosshard, Dr. Ralph Gomez, Dr. Michael Hiob, Dr. Christine Oechslein, Max Lazar, Ulrike Reuter, Michael Schulte, Uwe Schwarzat – all international experts and key opinion leaders. They share their detailed understanding of the various aspects of the validation process in clear and comprehensive style
blue inspection body celebrates 50 GMP audits
Münster (Germany), 20 November 2009. Two years after founding the company and just 18 months after gaining the accreditation blue inspection body GmbH announced today the successful execution of its 50th GMP audit. Further audit trips to China, India, Israel and various European countries have been scheduled already, meaning that in the first quarter 2010 the 75th audit is targeted to be completed. Blue, as a privately organised inspection body,